Economic Evaluation of Companion Diagnostic Testing for EGFR Mutations and First-Line Targeted Therapy in Advanced Non-Small Cell Lung Cancer Patients in South Korea

Open Access

Peer-reviewed

Research Article

Eun-A Lim,

Affiliation College of Pharmacy, Korea University, Sejong, Korea
⨯
Haeyoung Lee,

Affiliation College of Pharmacy, Korea University, Sejong, Korea

http://orcid.org/0000-0002-8259-920X

⨯
Eunmi Bae,

Affiliation College of Pharmacy, Korea University, Sejong, Korea
⨯
Jaeok Lim,

Affiliation College of Pharmacy, Korea University, Sejong, Korea
⨯
Young Kee Shin,

Affiliation College of Pharmacy, Seoul National University, Seoul, Korea
⨯
Sang-Eun Choi

* E-mail: sechoi@korea.ac.kr

Affiliation College of Pharmacy, Korea University, Sejong, Korea
⨯

Reader Comments (0)

Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Non-small cell lung cancer
Is the Subject Area "Non-small cell lung cancer" applicable to this article?

Thanks for your feedback.
Cost-effectiveness analysis
Is the Subject Area "Cost-effectiveness analysis" applicable to this article?

Thanks for your feedback.
Adenocarcinoma
Is the Subject Area "Adenocarcinoma" applicable to this article?

Thanks for your feedback.
Health economics
Is the Subject Area "Health economics" applicable to this article?

Thanks for your feedback.
Chemotherapy
Is the Subject Area "Chemotherapy" applicable to this article?

Thanks for your feedback.
Cancer detection and diagnosis
Is the Subject Area "Cancer detection and diagnosis" applicable to this article?

Thanks for your feedback.
Adenocarcinoma of the lung
Is the Subject Area "Adenocarcinoma of the lung" applicable to this article?

Thanks for your feedback.